INGM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
INGM is not a good buy right now for a Beginner focused on long-term investing, even with $50,000-$100,000 available. The stock has supportive analyst revisions and some AI/distribution tailwinds, but the current setup is technically weak and there is no strong proprietary buy signal. Because the user is impatient and wants an immediate decision, I would not add it now; I would wait for a cleaner trend confirmation rather than buying into a weak short-term price structure.
The trend is bearish in the near term. Price closed at 25.65, down 5.63% on the session, while MACD histogram is -0.344 and still expanding negatively, which confirms downward momentum. RSI_6 at 10.093 shows the stock is deeply oversold, but oversold alone is not a buy signal without reversal confirmation. Moving averages are converging, suggesting a possible inflection point, but the stock is still trading below pivot resistance at 27.36. Immediate support sits near S1 at 26.088 and S2 at 25.302; the current price is already close to S2, so downside is limited near term, but the chart does not yet show a confirmed rebound.
["Morgan Stanley raised its price target to $33 from $27.50.", "JPMorgan upgraded the stock to Neutral from Underweight and raised its target to $27.", "Truist lifted its target to $29 after a Q1 earnings beat and cited healthy IT spending.", "Raymond James raised its target to $34 and pointed to strong Q1 revenue growth and potential margin improvement.", "RBC highlighted Ingram Micro's exposure to AI infrastructure, GPUs, and Xvantage-driven efficiency gains.", "No recent negative news headlines in the last week."]
["The stock fell 5.63% in the latest session, showing near-term selling pressure.", "MACD remains negative and is worsening, indicating ongoing downside momentum.", "No signal from AI Stock Picker and no recent SwingMax signal.", "Hedge funds and insiders show no significant buying trend.", "No recent congress trading activity reported.", "Goldman Sachs warned that part of the recent rally was driven by valuation expansion and that enterprise IT spending could slow later in 2026 and 2027.", "Financial snapshot data was unavailable, so latest-quarter financial momentum cannot be confirmed from the provided data."]
Latest quarter details are not fully available in the provided snapshot, so a precise quarter-by-quarter financial review is limited. The only confirmed financial commentary is that Q1 revenue growth was strong, with double-digit growth across regions according to Truist, and Raymond James said Q1 revenue growth was strong but operating leverage was limited with some cash outflow normalization. The latest visible season referenced in the analyst notes is Q1 2026, and the tone suggests solid top-line momentum with mixed profitability/cash flow improvement.
Analyst sentiment has improved over the past two months. Price targets were repeatedly raised by Morgan Stanley, JPMorgan, Truist, Raymond James, RBC, Goldman Sachs, and Evercore. However, ratings remain mixed overall: Morgan Stanley is still Equal Weight, JPMorgan is Neutral, Goldman is Neutral, Truist is Hold, Evercore is In Line, with only Raymond James and RBC on the bullish side. Wall Street’s pro view is that enterprise demand, GPU distribution, AI infrastructure exposure, and better-than-expected IT spending support upside. The con view is that valuation has already expanded, some demand may have been pulled forward, and downside risk to later-period IT spending remains. Overall, the pros have improved, but the consensus is still cautious rather than strongly bullish.
